Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Michelson

Showing results (271-280 of 339) with videos related to

Pageof 34
Sort By:
British Journal of Haematology|November 1, 1993
Aprotinin reduces cardiopulmonary bypass-induced blood loss and inhibits fibrinolysis without influencing plateletsM A Orchard, C S Goodchild, C R Prentice, et al.
Journal of Thrombosis and Haemostasis : JTH|November 20, 2009
Targeted inhibition of the serotonin 5HT2A receptor improves coronary patency in an in vivo model of recurrent thrombosisK Przyklenk, A L Frelinger, M D Linden, et al.
Contemporary Clinical Trials|August 26, 2019
Ticagrelor versus placebo for the reduction of vaso-occlusive crises in pediatric sickle cell disease: Rationale and design of a randomized, double-blind, parallel-group, multicenter phase 3 study (HESTIA3)Matthew M Heeney, Miguel R Abboud, Carl Amilon, et al.
The Journal of Prevention of Alzheimer'S Disease|July 5, 2018
What Have We Learned from Expedition III and EPOCH Trials? Perspective of the CTAD Task ForceP S Aisen, E Siemers, D Michelson, et al.
Journal of Thrombosis and Haemostasis : JTH|September 17, 2011
Differences in platelet function in patients with acute myeloid leukemia and myelodysplasia compared to equally thrombocytopenic patients with immune thrombocytopeniaB Psaila, J B Bussel, A L Frelinger, et al.
Clinical Cardiology|May 20, 2008
The problem of persistent platelet activation in acute coronary syndromes and following percutaneous coronary interventionEugene Braunwald, Dominick Angiolillo, Eric Bates, et al.
Clinical Cardiology|May 20, 2008
Clinical considerations with the use of antiplatelet therapy in patients undergoing percutaneous coronary interventionEugene Braunwald, Dominick Angiolillo, Eric Bates, et al.
Clinical Cardiology|May 20, 2008
Antiplatelet strategies: evaluating their current role in the setting of acute coronary syndromesEugene Braunwald, Dominick Angiolillo, Eric Bates, et al.
Clinical Cardiology|May 20, 2008
Investigating the mechanisms of hyporesponse to antiplatelet approachesEugene Braunwald, Dominick Angiolillo, Eric Bates, et al.
Blood|February 12, 2005
Platelet activation in cystic fibrosisBrian P O'Sullivan, Matthew D Linden, Andrew L Frelinger, et al.
Pageof 34

Showing results (271-280 of 339) with videos related to

Sort By:
Pageof 34
British Journal of Haematology|November 1, 1993
Aprotinin reduces cardiopulmonary bypass-induced blood loss and inhibits fibrinolysis without influencing plateletsM A Orchard, C S Goodchild, C R Prentice, et al.
Journal of Thrombosis and Haemostasis : JTH|November 20, 2009
Targeted inhibition of the serotonin 5HT2A receptor improves coronary patency in an in vivo model of recurrent thrombosisK Przyklenk, A L Frelinger, M D Linden, et al.
Contemporary Clinical Trials|August 26, 2019
Ticagrelor versus placebo for the reduction of vaso-occlusive crises in pediatric sickle cell disease: Rationale and design of a randomized, double-blind, parallel-group, multicenter phase 3 study (HESTIA3)Matthew M Heeney, Miguel R Abboud, Carl Amilon, et al.
The Journal of Prevention of Alzheimer'S Disease|July 5, 2018
What Have We Learned from Expedition III and EPOCH Trials? Perspective of the CTAD Task ForceP S Aisen, E Siemers, D Michelson, et al.
Journal of Thrombosis and Haemostasis : JTH|September 17, 2011
Differences in platelet function in patients with acute myeloid leukemia and myelodysplasia compared to equally thrombocytopenic patients with immune thrombocytopeniaB Psaila, J B Bussel, A L Frelinger, et al.
Clinical Cardiology|May 20, 2008
The problem of persistent platelet activation in acute coronary syndromes and following percutaneous coronary interventionEugene Braunwald, Dominick Angiolillo, Eric Bates, et al.
Clinical Cardiology|May 20, 2008
Clinical considerations with the use of antiplatelet therapy in patients undergoing percutaneous coronary interventionEugene Braunwald, Dominick Angiolillo, Eric Bates, et al.
Clinical Cardiology|May 20, 2008
Antiplatelet strategies: evaluating their current role in the setting of acute coronary syndromesEugene Braunwald, Dominick Angiolillo, Eric Bates, et al.
Clinical Cardiology|May 20, 2008
Investigating the mechanisms of hyporesponse to antiplatelet approachesEugene Braunwald, Dominick Angiolillo, Eric Bates, et al.
Blood|February 12, 2005
Platelet activation in cystic fibrosisBrian P O'Sullivan, Matthew D Linden, Andrew L Frelinger, et al.
Pageof 34